Patents by Inventor Bryan C. Dickinson

Bryan C. Dickinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11913081
    Abstract: A proximity dependent split T7 RNAP (RNA polymerase) sensor using continuous molecular evolution is described. The versatility of the platform is described by creating robust light and small molecule-responsive genetic sensors. The activity-responsive RNAP platform dramatically simplifies and expands genetic circuit creation, and opens new opportunities in protein engineering, synthetic biology, and bioengineering.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: February 27, 2024
    Assignee: The University of Chicago
    Inventors: Bryan C. Dickinson, Jinyue Pu, Julia Zinkus
  • Publication number: 20220048962
    Abstract: Aspects of the disclosure relate to a RNA regulatory system comprising at least one of each: i) a RNA hairpin binding domain; ii) a RNA targeting molecule comprising a RNA targeting region and at least one hairpin structure, wherein the hairpin structure of the RNA targeting molecule specifically binds to i; and iii) a RNA regulatory domain.
    Type: Application
    Filed: January 3, 2020
    Publication date: February 17, 2022
    Applicant: The University of Chicago
    Inventors: Bryan C. DICKINSON, Simone RAUCH
  • Publication number: 20200332371
    Abstract: A proximity dependent split T7 RNAP (RNA polymerase) sensor using continuous molecular evolution is described. The versatility of the platform is described by creating robust light and small molecule-responsive genetic sensors. The activity-responsive RNAP platform dramatically simplifies and expands genetic circuit creation, and opens new opportunities in protein engineering, synthetic biology, and bioengineering.
    Type: Application
    Filed: June 6, 2017
    Publication date: October 22, 2020
    Applicant: The University of Chicago
    Inventors: Bryan C. DICKINSON, Jinyue PU, Julia ZINKUS
  • Patent number: 10413583
    Abstract: Synthetic probes for detecting the activity of enzymes that catalyze reactions of post-translationally modified cysteine residues are described. The probes include “turn-on” probes that include a carbamate linkage that is cleaved via an intramolecular reaction with a free thiol produced by an enzyme catalyzed activity. The probes also include ratiometric, Michael addition-based probes that respond to enzymatic activity by a change in structure that results in a change in fluorescence properties. Methods of using the probes to detect enzymatic activity and disease are described. For example, the probes can be used to detect enzymatic activity in a variety of samples, including live cells and heterogeneous tissues. In addition, prodrugs that can be activated by enzymes that catalyze reactions of post-translationally modified cysteine residues and methods of using the prodrugs to treat disease are described.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: September 17, 2019
    Assignee: The University of Chicago
    Inventors: Bryan C. Dickinson, Rahul S. Kathayat, Michael W. Beck
  • Publication number: 20180147250
    Abstract: Synthetic probes for detecting the activity of enzymes that catalyze reactions of post-translationally modified cysteine residues are described. The probes include “turn-on” probes that include a carbamate linkage that is cleaved via an intramolecular reaction with a free thiol produced by an enzyme catalyzed activity. The probes also include ratiometric, Michael addition-based probes that respond to enzymatic activity by a change in structure that results in a change in fluorescence properties. Methods of using the probes to detect enzymatic activity and disease are described. For example, the probes can be used to detect enzymatic activity in a variety of samples, including live cells and heterogeneous tissues. In addition, prodrugs that can be activated by enzymes that catalyze reactions of post-translationally modified cysteine residues and methods of using the prodrugs to treat disease are described.
    Type: Application
    Filed: November 30, 2017
    Publication date: May 31, 2018
    Inventors: Bryan C. Dickinson, Rahul S. Kathayat, Michael W. Beck